Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Atorvastatin + Metformin |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Atorvastatin | Lipitor | Atogal | Lipitor (atorvastatin) may inhibit farnesylation and geranylgeranylation of small GTP-binding proteins, potentially causing cell cycle arrest in tumor cells (PMID: 31397499). | |
| Metformin | Glucophage | Apo-Metformin | mTOR Inhibitor 51 | Glucophage (metformin) inhibits part of the mitochondrial respiratory chain and may exert antineoplastic effects through inhibition of mTOR and is FDA approved for type 2 diabetes (FDA.gov). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT02497638 | Phase II | Atorvastatin + Metformin | LIpitor and biGuanide to Androgen Delay Trial | Withdrawn | CAN | 0 |
| NCT01980823 | Phase I | Atorvastatin + Metformin | Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer | Completed | USA | 0 |